Health and Human Services News and Research

RSS

Quick action can save lives of people with severe hypoglycemia

People with diabetes and their friends and relatives will be better prepared to spot the signs of dangerously low blood sugar using new resources the Hormone Health Network has introduced.

11 Sep 2019

NIH partners with Apple and Harvard for long-term study of women's health

The National Institutes of Health, Apple, and the Harvard T. H. Chan School of Public Health announced their research partnership for a major long-term study of women's health.

11 Sep 2019

Two uveitis drugs perform similarly in a head-to-head clinical trial

Methotrexate and the more expensive mycophenolate mofetil performed similarly in a head-to-head clinical trial that compared the two drugs for treating noninfectious uveitis, an eye disease that accounts for up to 15% of blindness in the U. S.

11 Sep 2019

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

10 Sep 2019

Primary care physicians’ perceptions of barriers to chronic kidney disease management

On July 10, the Department of Health and Human Services announced they were aiming to reduce the number of Americans developing end-stage renal disease by 25% by 2030.

10 Sep 2019

Oral antibiotics that kill gut microorganisms can alter immune response to flu vaccines

The normal human gut microbiome is a flourishing community of microorganisms, some of which can affect the human immune system. In a new paper published this week in Cell, researchers found that oral antibiotics, which can kill gut microorganisms, can alter the human immune response to seasonal influenza vaccination.

8 Sep 2019

FDA approves first drug to treat patients with rare lung condition

The U.S. Food and Drug Administration today approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition.

7 Sep 2019

New $3.75 million grant to support second phase of Indiana Geriatrics Workforce Enhancement Program

With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.

4 Sep 2019

FDA recommends health care facilities to transition away from fixed endcap duodenoscope models

Today, the U.S. Food and Drug Administration is recommending that duodenoscope manufacturers and health care facilities transition to different types of duodenoscopes that may pose less risk to patient safety.

31 Aug 2019

Statement on FDA and CDC collaboration to investigate respiratory illnesses related to e-cigarette use

Both the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention are working tirelessly to investigate the distressing incidents of severe respiratory disease associated with use of e-cigarette products.

30 Aug 2019

Study reveals outcomes in transplant patients after declined offers of deceased donor kidneys

Patients who die waiting for a kidney, or who are removed from the transplant waitlist for poor

30 Aug 2019

UNT Health Science Center receives federal funding to improve health care for older adults

UNT Health Science Center and its community partners are expanding their efforts to improve health care for older adults with the support of a $3.75 million federal grant.

29 Aug 2019

NIH announces new round of funding for Research Centers in Minority Institutions

The National Institute on Minority Health and Health Disparities, part of the National Institutes of Health, has funded three new awards and renewed the awards of eight institutions previously funded under the Research Centers in Minority Institutions Specialized Centers program.

26 Aug 2019

FDA finds inconsistent amounts of belladonna in certain homeopathic teething tablets

The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label.

23 Aug 2019

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

19 Aug 2019

Loss of cells in the brain found to be associated with stuttering

Researchers believe that stuttering - a potentially lifelong and debilitating speech disorder - stems from problems with the circuits in the brain that control speech, but precisely how and where these problems occur is unknown.

19 Aug 2019

FDA approves first spinal tether device to treat children with idiopathic scoliosis

The U.S. Food and Drug Administration today approved the first spinal tether device intended to be used in children and adolescents to correct the most common form of scoliosis, called idiopathic scoliosis, that has not responded to conservative treatment options, such as external bracing.

18 Aug 2019

FDA approves new drug to treat patients with myelofibrosis

Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.

18 Aug 2019

FDA approves novel device to treat symptoms associated with advanced heart failure

The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.

18 Aug 2019

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.

14 Aug 2019

Health and Human Services News and Research

Quick action can save lives of people with severe hypoglycemia

NIH partners with Apple and Harvard for long-term study of women's health

Two uveitis drugs perform similarly in a head-to-head clinical trial

NIAID experts call for innovative research on STIs

Primary care physicians’ perceptions of barriers to chronic kidney disease management

Oral antibiotics that kill gut microorganisms can alter immune response to flu vaccines

FDA approves first drug to treat patients with rare lung condition

New $3.75 million grant to support second phase of Indiana Geriatrics Workforce Enhancement Program

FDA recommends health care facilities to transition away from fixed endcap duodenoscope models

Statement on FDA and CDC collaboration to investigate respiratory illnesses related to e-cigarette use

Study reveals outcomes in transplant patients after declined offers of deceased donor kidneys

UNT Health Science Center receives federal funding to improve health care for older adults

NIH announces new round of funding for Research Centers in Minority Institutions

FDA finds inconsistent amounts of belladonna in certain homeopathic teething tablets

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

Loss of cells in the brain found to be associated with stuttering

FDA approves first spinal tether device to treat children with idiopathic scoliosis

FDA approves new drug to treat patients with myelofibrosis

FDA approves novel device to treat symptoms associated with advanced heart failure

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News